Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125543141 | 12554314 | 1 | I | 20160705 | 20160713 | 20160713 | EXP | US-ASTRAZENECA-2016SE73208 | ASTRAZENECA | 71.00 | YR | M | Y | 103.50000 | KG | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125543141 | 12554314 | 1 | PS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | U | 19962 | 50 | MG | MODIFIED-RELEASE TABLET | BID | ||||||
| 125543141 | 12554314 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | Oral | U | 0 | 1 | DF | CAPSULE | Q12H | ||||||
| 125543141 | 12554314 | 3 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0 | .5 | MG | TABLET | TID | |||||||
| 125543141 | 12554314 | 4 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Oral | 0 | 500 | MG | QD | ||||||||
| 125543141 | 12554314 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 0 | 180 | MG | BID | ||||||||
| 125543141 | 12554314 | 6 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Oral | 0 | 324 | MG | TABLET | QD | |||||||
| 125543141 | 12554314 | 7 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | 1 | DF | CAPSULE | QD | |||||||
| 125543141 | 12554314 | 8 | C | RESVERATROL | RESVERATROL | 1 | Oral | 0 | 250 | MG | TABLET | QD | |||||||
| 125543141 | 12554314 | 9 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 0 | 150 | MG | QD | ||||||||
| 125543141 | 12554314 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125543141 | 12554314 | 11 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 0 | 400 | IU | CAPSULE | QD | |||||||
| 125543141 | 12554314 | 12 | C | CARTIA XT | DILTIAZEM HYDROCHLORIDE | 1 | 0 | 180 | MG | BID | |||||||||
| 125543141 | 12554314 | 13 | C | XARELTO | RIVAROXABAN | 1 | 0 | 20 | MG | QD | |||||||||
| 125543141 | 12554314 | 14 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | AS NEEDED | 0 | |||||||||||
| 125543141 | 12554314 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | 40 | MG | QD | |||||||||
| 125543141 | 12554314 | 16 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | 20 | MG | QD | |||||||||
| 125543141 | 12554314 | 17 | C | ANTI-GAS MEDICATION | 2 | DAILY | 0 | ||||||||||||
| 125543141 | 12554314 | 18 | C | OMEGA-3 FISH OIL | FISH OILOMEGA-3 FATTY ACIDS | 1 | DAILY | 0 | |||||||||||
| 125543141 | 12554314 | 19 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125543141 | 12554314 | 3 | Anxiety |
| 125543141 | 12554314 | 9 | Dyspepsia |
| 125543141 | 12554314 | 14 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125543141 | 12554314 | OT |
| 125543141 | 12554314 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125543141 | 12554314 | Atrial fibrillation | |
| 125543141 | 12554314 | Hypertension | |
| 125543141 | 12554314 | Uterine cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125543141 | 12554314 | 2 | 20160603 | 0 |